Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Guangzhou Paizhen Biotechnology

Request full access

Accelerating gene therapy product development by providing an integrated one-stop solution including plasmid, viral vector, fill-finish and QC analytical services

Houston, United StatesFounded 2014Biotech & Life Sciences

About Guangzhou Paizhen Biotechnology

PackGene is a rapidly growing Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) specializing in recombinant adeno-associated virus (AAV) vector production. The company provides a comprehensive range of services, from research-grade to clinical-grade plasmid DNA and AAV viral vector production. PackGene's proprietary technology platform utilizes the triple plasmid transfection HEK293 cell process, which is central to delivering high purity, high titer, high infectivity, and high yield AAV vectors, capable of producing up to 1E17 vector genomes per batch.

PackGene serves a diverse clientele, including academic institutions, biotechnology firms, and pharmaceutical companies engaged in gene therapy research and development. The company operates in the biopharmaceutical market, focusing on gene therapy applications that require high-quality AAV vectors for preclinical and clinical studies.

The business model is service-based, generating revenue through the provision of AAV vector production services. Clients pay for the production of custom AAV vectors tailored to their specific research and clinical needs. Additionally, PackGene offers quality control assays to ensure the identity, purity, content potency, and safety of the AAV vectors produced.

Source: Dealroom company data

At a glance

Status
Operational
Employees
54
Open positions
7
Dealroom signal
33.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Dec 2023 $14M $55M SDIC Fund Management ↗
SERIES C✓Equity / VC Apr 2023 $0 — IFSC ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Guangzhou Paizhen Biotechnology website traffic

Latest recorded traffic for Guangzhou Paizhen Biotechnology is 15K monthly website visits, up 111.3% over the last three months. Guangzhou Paizhen Biotechnology's team declined 5.3% over the past year.

Latest monthly visits15K 3-month web change+111.3% 1-year team growth-5.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Guangzhou Paizhen Biotechnology in the Houston ecosystem

Live from Dealroom

The Guangzhou Paizhen Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Kaitai Capital

Series A4 investors entered at this stage

  • Tengye Venture Capital
  • Sequoia
  • Cathay Capital
  • Decheng Capital

Series B and later3 investors entered at this stage

  • CMB International Capital
  • IFSC
  • SDIC Fund Management

Other known investors5 additional known investors

  • Guangzhou Development District Industrial Fund
  • Guangzhou Emerging Fund
  • Guoju Venture Capital
  • Huacheng Ruisi
  • Sanmei Investment
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States81%
🇨🇳 China14.3%
🇬🇧 United Kingdom2.4%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Guangzhou Paizhen Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Guangzhou Paizhen Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.